miR-23a repressed the expression of ESRP1 and consequently affected CD44 splicing, as well as FGFR2 IIIb and FGFR2 IIIc mRNA levels in pancreatic cancer cells. This evidence concerns the gene ESRP1 and pancreatic neoplasm.